Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Researchers develop a mouse model of 3q.29 deletion-driven psychiatric disorder

April 3, 2020

Topline phase Ib/IIa results for AB-2004 in patients with ASD

April 3, 2020

Nicotinic acetylcholine receptors as potential target for treating synucleinopathies

April 2, 2020

New potent and selective ATP-competitive mTOR inhibitor with brain penetrance for CNS disorders

April 2, 2020

Biochemical Agent describes IGF-1 long chimeric proteins

April 2, 2020

DSR-141562 shows promise in preclinical schizophrenia-related behavioral assays

April 2, 2020

Positive phase II data for THN-102 in patients with Parkinson's disease and EDS

April 2, 2020

Common form of muscular dystrophy causes damage through hypoxia

April 1, 2020

Otsuka studies OPC-214870 in subjects with history of photoparoxysmal response on EEG

March 31, 2020

New Parkinson's disease model induced via dysregulation in dopamine sequestration

March 31, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...